- Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma
-
Murakami M, Fujimaki T, Asano S, Nakaguchi , Yamada SM, Hoya K, Yamazaki K, Ishida Y, Matsuno A
- KMID: 1058828
- Yonsei Med J.
- 2011 Nov;52(6):1031-1034.
- doi: 10.3349/ymj.2011.52.6.1031
High-dose methotrexate-based chemotherapy has extended survival in patients with primary central nervous system lymphoma (PCNSL). However, although salvage treatment is necessary in recurrent and refractory PCNSL, this has not been... -
- CITED
-
- Close
- SHARE
-
- Close
